Selective serotonin reuptake inhibitor antidepressants can actually promote the proliferation of neuronal cells and boost neuroplasticity in both in vitro and in vivo, evidence suggests. Dr. Javad Verdi and his team, Tehran University of Medical Sciences, Iran proposed that citalopram, a selective serotonin reuptake inhibitor, can increase the efficacy of bone marrow mesenchymal stem cells (BMSCs) differentiating into neuronal-like cells.
Experimental results confirmed that citalopram can improve the neuronal-like cell differentiation of BMSCs by increasing cell proliferation and survival while maintaining their neuronal characteristics. These results were published in Neural Regeneration Research
(Vol. 9, No. 8, 2014).